Compound | Level | Clearance | Spillover | Half-Time |
---|---|---|---|---|
nmol/L | l/min | nmol/min | min | |
Noradrenergic | ||||
VMA | 30.0 | 0.6 | 21.0 | 32.0 |
MHPG-S | 23.0 | 0.3* | 7.4* | |
MHPG | 20.0 | 1.3 | 25.0 | 28.0 |
DHPG-S | 6.6 | 0.3* | 1.7* | |
NMN-S | 6.6 | 0.1* | 0.7* | >60.0 |
DHPG | 4.7 | 2.4 | 12.0 | |
NE-S | 3.4 | 0.1* | 0.5* | |
Norepinephrine | 1.0 | 1.7 | 2.6 | 2.0 |
NMN | 0.3 | 1.4 | 0.4 | <4.0 |
Adrenergic | ||||
MN-S | 3.9 | 0.1* | 0.5* | >60.0 |
Epinephrine-S | 0.5 | 0.2* | 0.1* | |
MN | 0.3 | 1.4 | 0.5 | <4.0 |
Epinephrine | 0.2 | 2.3 | 0.5 | ∼3.0 |
Dopaminergic | ||||
HVA | 70.0 | 0.8 | 63.0 | 40.0 |
DA-S | 9.7 | 0.1* | 1.3 | 148.0 |
DOPAC | 8.9 | 0.5* | >4.1* | |
3-M-tyramine-S | 2.8 | 0.12* | 0.3* | >60.0 |
DA | 0.1 | 2.8** | 0.3 | ∼2.0 |
3-M-tyramine | 0.03 | 0.5 | 0.02 | |
DOPA | ||||
3-M-tyrosine | 87.0 | 0.005 | 0.4 | |
DOPA | 8.9 | 0.9 | 7.4 | |
3-M-tyrosine-S | 2.8 | 0.1 | 0.3 | >60.0 |
DOPA-S | 2.1 |
|
|
|